2-[3,4-bis(trifluoromethyl)pyrazol-1-id-5-yl]-4-methylpyridine;2-[3,4-bis(trifluoromethyl)pyrazol-1-id-5-yl]pyridine;bis(2-(2,4-difluorobenzene-6-id-1-yl)-4-methylpyridine);bis(2-(4,5-difluoropyrazol-2-id-3-yl)pyridine);tris(2-(4-fluorobenzene-6-id-1-yl)-4-methylpyridine);pentakis(iridium);2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine
C106H66F26Ir5N20-10 — CID 158260535
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[3,4-bis(trifluoromethyl)pyrazol-1-id-5-yl]-4-methylpyridine;2-[3,4-bis(trifluoromethyl)pyrazol-1-id-5-yl]pyridine;bis(2-(2,4-difluorobenzene-6-id-1-yl)-4-methylpyridine);bis(2-(4,5-difluoropyrazol-2-id-3-yl)pyridine);tris(2-(4-fluorobenzene-6-id-1-yl)-4-methylpyridine);pentakis(iridium);2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine
2-[3,4-bis(trifluoromethyl)pyrazol-1-id-5-yl]-4-methylpyridine;2-[3,4-bis(trifluoromethyl)pyrazol-1-id-5-yl]pyridine;bis(2-(2,4-difluorobenzene-6-id-1-yl)-4-methylpyridine);bis(2-(4,5-difluoropyrazol-2-id-3-yl)pyridine);tris(2-(4-fluorobenzene-6-id-1-yl)-4-methylpyridine);pentakis(iridium);2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine (PubChem CID 158260535) has the molecular formula C106H66F26Ir5N20-10 and a molecular weight of 3074.87 g/mol. Its IUPAC name is 2-[3,4-bis(trifluoromethyl)pyrazol-1-id-5-yl]-4-methylpyridine;2-[3,4-bis(trifluoromethyl)pyrazol-1-id-5-yl]pyridine;bis(2-(2,4-difluorobenzene-6-id-1-yl)-4-methylpyridine);bis(2-(4,5-difluoropyrazol-2-id-3-yl)pyridine);tris(2-(4-fluorobenzene-6-id-1-yl)-4-methylpyridine);pentakis(iridium);2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine.
Molecular Properties
| Compound Name | 2-[3,4-bis(trifluoromethyl)pyrazol-1-id-5-yl]-4-methylpyridine;2-[3,4-bis(trifluoromethyl)pyrazol-1-id-5-yl]pyridine;bis(2-(2,4-difluorobenzene-6-id-1-yl)-4-methylpyridine);bis(2-(4,5-difluoropyrazol-2-id-3-yl)pyridine);tris(2-(4-fluorobenzene-6-id-1-yl)-4-methylpyridine);pentakis(iridium);2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine |
|---|---|
| PubChem CID | 158260535 |
| Molecular Formula | C106H66F26Ir5N20-10 |
| Molecular Weight | 3074.87 g/mol |
| Exact Mass | 3077.36 |
| IUPAC Name | 2-[3,4-bis(trifluoromethyl)pyrazol-1-id-5-yl]-4-methylpyridine;2-[3,4-bis(trifluoromethyl)pyrazol-1-id-5-yl]pyridine;bis(2-(2,4-difluorobenzene-6-id-1-yl)-4-methylpyridine);bis(2-(4,5-difluoropyrazol-2-id-3-yl)pyridine);tris(2-(4-fluorobenzene-6-id-1-yl)-4-methylpyridine);pentakis(iridium);2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine |
| SMILES | Cc1ccnc(-c2[c-]cc(F)cc2)c1.Cc1ccnc(-c2[c-]cc(F)cc2)c1.Cc1ccnc(-c2[c-]cc(F)cc2)c1.Cc1ccnc(-c2[c-]cc(F)cc2F)c1.Cc1ccnc(-c2[c-]cc(F)cc2F)c1.Cc1ccnc(-c2[n-]nc(C(F)(F)F)c2C(F)(F)F)c1.FC(F)(F)c1cc(-c2ccccn2)[n-]n1.FC(F)(F)c1n[n-]c(-c2ccccn2)c1C(F)(F)F.Fc1n[n-]c(-c2ccccn2)c1F.Fc1n[n-]c(-c2ccccn2)c1F.[Ir].[Ir].[Ir].[Ir].[Ir] |
| InChI | InChI=1S/2C12H8F2N.3C12H9FN.C11H6F6N3.C10H4F6N3.C9H5F3N3.2C8H4F2N3.5Ir/c2*1-8-4-5-15-12(6-8)10-3-2-9(13)7-11(10)14;3*1-9-6-7-14-12(8-9)10-2-4-11(13)5-3-10;1-5-2-3-18-6(4-5)8-7(10(12,13)14)9(20-19-8)11(15,16)17;11-9(12,13)6-7(5-3-1-2-4-17-5)18-19-8(6)10(14,15)16;10-9(11,12)8-5-7(14-15-8)6-3-1-2-4-13-6;2*9-6-7(12-13-8(6)10)5-3-1-2-4-11-5;;;;;/h2*2,4-7H,1H3;3*2,4-8H,1H3;2-4H,1H3;1-4H;1-5H;2*1-4H;;;;;/q10*-1;;;;; |
| InChIKey | YWBZSVZCKPSFRP-UHFFFAOYSA-N |
| XLogP | 26.71 |
| TPSA | 263.85 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 15 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 157 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3074.87 |
| LogP ≤ 5 | 26.71 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 15 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158260535 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.